When it comes to vaccine adjuvants, not all alum is equal
Aluminium adjuvants should not be used in trial placebos according to UK scientists who say the differing physical and biological properties of alum salt forms makes some safer than others.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs